
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
Aimei Health Technology Co., Ltd Ordinary Share (AFJK)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: AFJK (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 9.62% | Avg. Invested days 299 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 68.26M USD | Price to earnings Ratio 48.48 | 1Y Target Price - |
Price to earnings Ratio 48.48 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 10.24 - 11.20 | Updated Date 06/29/2025 |
52 Weeks Range 10.24 - 11.20 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.23 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE 48.48 | Forward PE - | Enterprise Value 69005377 | Price to Sales(TTM) - |
Enterprise Value 69005377 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 6121730 | Shares Floating 3988921 |
Shares Outstanding 6121730 | Shares Floating 3988921 | ||
Percent Insiders 33.6 | Percent Institutions 69.71 |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Ordinary Share
Company Overview
History and Background
It is impossible to provide the history of Aimei Health Technology Co., Ltd Ordinary Share as this company is not listed on any US exchange and information is very limited. In order to give an accurate answer, I need a company that is listed on the US Stock Exchange and has financials and available data.
Core Business Areas
Leadership and Structure
Due to limited information on Aimei Health Technology Co., Ltd Ordinary Share, I cannot outline its leadership team or organizational structure.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
I cannot provide a relevant overview of the industry Aimei Health Technology Co., Ltd Ordinary Share operates in without sufficient information about their specific business activities.
Positioning
Without data on Aimei Health Technology Co., Ltd Ordinary Share's operations and market presence, it's impossible to determine its positioning in the industry.
Total Addressable Market (TAM)
Without the specific information on Aimei Health Technology Co., Ltd Ordinary Share I am unable to determine TAM
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Without knowledge of Aimei Health Technology Co., Ltd Ordinary Share's competitors, I can't assess its competitive advantages or disadvantages.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends for Aimei Health Technology Co., Ltd Ordinary Share are unavailable.
Future Projections: Future growth projections for Aimei Health Technology Co., Ltd Ordinary Share are unavailable.
Recent Initiatives: Recent strategic initiatives undertaken by Aimei Health Technology Co., Ltd Ordinary Share are unknown.
Summary
Due to limited information, a comprehensive analysis of Aimei Health Technology Co., Ltd Ordinary Share cannot be performed. The company's financial health, competitive positioning, and growth prospects remain unknown.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Publicly available company data sources were researched but insufficient information was found.
Disclaimers:
The analysis is based on extremely limited publicly available information and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Ordinary Share
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website |
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.